Vimarsana
Biggest News Aggregation in the World

Page 15 - Poster Section News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Poster Section. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Poster Section Today - Breaking & Trending Today

Bantam Pharmaceutical and Collaborators to Present New Data in Support of its lead drug BTM-3566 at AACR Annual Meeting 2022 - Vimarsana News

Bantam Pharmaceutical and Collaborators to Present New Data in Support of its lead drug BTM-3566 at AACR Annual Meeting 2022

/PRNewswire/ -- Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, will...

ESSA Pharma Announces the Presentation of Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders - Vimarsana News

ESSA Pharma Announces the Presentation of Preclinical Data for its First Generation of Androgen Receptor N-Terminal Domain Degraders

/PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for...

F-star Therapeutics, Inc.: F-star Therapeutics Presents a Novel LAG-3 Reduction and Shedding Mechanism with FS118 at AACR 2022 - Vimarsana News

F-star Therapeutics, Inc.: F-star Therapeutics Presents a Novel LAG-3 Reduction and Shedding Mechanism with FS118 at AACR 2022

Unique Structure and Tetravalency of FS118 Is Required to Modulate LAG-3 Cell Surface ExpressionCAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., April 08, 2022(NASDAQ: FSTX), a clinical-stage biopharmaceutical

Investegate |Ultimovacs ASA Announcements | Ultimovacs ASA: Ultimovacs Presents TET Platform Pre-Clinical Data at AACR 2022 Supporting Clinical Development - Vimarsana News

Investegate |Ultimovacs ASA Announcements | Ultimovacs ASA: Ultimovacs Presents TET Platform Pre-Clinical Data at AACR 2022 Supporting Clinical Development

Investegate announcements from Ultimovacs ASA, Ultimovacs Presents TET Platform Pre-Clinical Data at AACR 2022 Supporting Clinical Development

New Data at AACR Showcase Reaction Biology's Innovative Approach to Oncology Drug Discovery Services - Vimarsana News

New Data at AACR Showcase Reaction Biology's Innovative Approach to Oncology Drug Discovery Services

/PRNewswire/ -- Reaction Biology ("Reaction" or the "Company"), an industry- leading provider of drug discovery services, today announced that twelve abstracts...